| Product Code: ETC9964492 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, the United States imported dog vaccines primarily from Austria, Metropolitan France, Italy, Germany, and Brazil. Despite the low concentration with a Herfindahl-Hirschman Index (HHI), the market experienced a significant decline in Compound Annual Growth Rate (CAGR) at -31.87% from 2020 to 2024. Furthermore, the growth rate in 2024 dropped even further at -39.06% compared to the previous year. This data suggests a challenging landscape for dog vaccine import shipments in the United States, potentially influenced by various factors impacting the market dynamics.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Dog Vaccine Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Dog Vaccine Market Revenues & Volume, 2022 & 2032F |
3.3 United States (US) Dog Vaccine Market - Industry Life Cycle |
3.4 United States (US) Dog Vaccine Market - Porter's Five Forces |
3.5 United States (US) Dog Vaccine Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 United States (US) Dog Vaccine Market Revenues & Volume Share, By Disease Type, 2022 & 2032F |
3.7 United States (US) Dog Vaccine Market Revenues & Volume Share, By Route of Administration, 2022 & 2032F |
3.8 United States (US) Dog Vaccine Market Revenues & Volume Share, By Duration of Immunity, 2022 & 2032F |
3.9 United States (US) Dog Vaccine Market Revenues & Volume Share, By Component, 2022 & 2032F |
4 United States (US) Dog Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing pet ownership rates in the United States |
4.2.2 Rising awareness about the importance of pet healthcare and preventive measures |
4.2.3 Technological advancements leading to the development of more effective and convenient vaccines |
4.3 Market Restraints |
4.3.1 High cost associated with pet vaccinations |
4.3.2 Concerns about potential side effects of vaccines among pet owners |
4.3.3 Limited access to veterinary services in certain regions |
5 United States (US) Dog Vaccine Market Trends |
6 United States (US) Dog Vaccine Market, By Types |
6.1 United States (US) Dog Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Dog Vaccine Market Revenues & Volume, By Type, 2022 - 2032F |
6.1.3 United States (US) Dog Vaccine Market Revenues & Volume, By Modified/ Attenuated Live, 2022 - 2032F |
6.1.4 United States (US) Dog Vaccine Market Revenues & Volume, By Inactivated (Killed), 2022 - 2032F |
6.1.5 United States (US) Dog Vaccine Market Revenues & Volume, By Others, 2022 - 2032F |
6.2 United States (US) Dog Vaccine Market, By Disease Type |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Dog Vaccine Market Revenues & Volume, By Canine Distemper, 2022 - 2032F |
6.2.3 United States (US) Dog Vaccine Market Revenues & Volume, By Canine Infectious Respiratory Disease Complex (CIRDC), 2022 - 2032F |
6.2.4 United States (US) Dog Vaccine Market Revenues & Volume, By Canine Parvovirosis/ Parvovirus Disease, 2022 - 2032F |
6.2.5 United States (US) Dog Vaccine Market Revenues & Volume, By Canine Leptospirosis, 2022 - 2032F |
6.2.6 United States (US) Dog Vaccine Market Revenues & Volume, By Canine Lyme Disease, 2022 - 2032F |
6.2.7 United States (US) Dog Vaccine Market Revenues & Volume, By Infectious Canine Hepatitis, 2022 - 2032F |
6.2.8 United States (US) Dog Vaccine Market Revenues & Volume, By Other Diseases, 2022 - 2032F |
6.2.9 United States (US) Dog Vaccine Market Revenues & Volume, By Other Diseases, 2022 - 2032F |
6.3 United States (US) Dog Vaccine Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Dog Vaccine Market Revenues & Volume, By Injectable, 2022 - 2032F |
6.3.3 United States (US) Dog Vaccine Market Revenues & Volume, By Intranasal, 2022 - 2032F |
6.3.4 United States (US) Dog Vaccine Market Revenues & Volume, By Oral, 2022 - 2032F |
6.4 United States (US) Dog Vaccine Market, By Duration of Immunity |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Dog Vaccine Market Revenues & Volume, By 1-year, 2022 - 2032F |
6.4.3 United States (US) Dog Vaccine Market Revenues & Volume, By 3- Year, 2022 - 2032F |
6.4.4 United States (US) Dog Vaccine Market Revenues & Volume, By Others, 2022 - 2032F |
6.5 United States (US) Dog Vaccine Market, By Component |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Dog Vaccine Market Revenues & Volume, By Combined Vaccines, 2022 - 2032F |
6.5.3 United States (US) Dog Vaccine Market Revenues & Volume, By Mono Vaccines, 2022 - 2032F |
7 United States (US) Dog Vaccine Market Import-Export Trade Statistics |
7.1 United States (US) Dog Vaccine Market Export to Major Countries |
7.2 United States (US) Dog Vaccine Market Imports from Major Countries |
8 United States (US) Dog Vaccine Market Key Performance Indicators |
8.1 Percentage of pet owners who adhere to recommended vaccination schedules |
8.2 Number of veterinary clinics offering canine vaccination services |
8.3 Rate of adoption of new and advanced dog vaccines |
8.4 Number of reported cases of preventable diseases in unvaccinated dogs |
8.5 Level of government regulations and incentives supporting dog vaccination programs |
9 United States (US) Dog Vaccine Market - Opportunity Assessment |
9.1 United States (US) Dog Vaccine Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 United States (US) Dog Vaccine Market Opportunity Assessment, By Disease Type, 2022 & 2032F |
9.3 United States (US) Dog Vaccine Market Opportunity Assessment, By Route of Administration, 2022 & 2032F |
9.4 United States (US) Dog Vaccine Market Opportunity Assessment, By Duration of Immunity, 2022 & 2032F |
9.5 United States (US) Dog Vaccine Market Opportunity Assessment, By Component, 2022 & 2032F |
10 United States (US) Dog Vaccine Market - Competitive Landscape |
10.1 United States (US) Dog Vaccine Market Revenue Share, By Companies, 2025 |
10.2 United States (US) Dog Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here